Basic Information
| LncRNA/CircRNA Name | DUXAP8 |
| Synonyms | NA |
| Region | GRCh38_22:15784959-15829984 |
| Ensemble | ENSG00000206195 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, Western blot, etc. |
| Sample | bladder cancer tissues, cell lines (SV-HUC-1, T24, RT4, J82) |
| Expression Pattern | up-regulated |
| Function Description | it was in a positive correlation with the TNM stage and tumor size, but negatively correlated with the total survival time. promote the progression of bladder cancer through inhibiting PTEN. |
| Pubmed ID | 29917188 |
| Year | 2018 |
| Title | Mechanism of lncRNA DUXAP8 in promoting proliferation of bladder cancer cells by regulating PTEN. |
External Links
| Links for DUXAP8 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |